Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

  • Sabrina Thalita Reis1, 2Email author,
  • José Pontes-Junior1, 2, 3,
  • Alberto Azoubel Antunes1, 3,
  • Marcos Francisco Dall’Oglio1, 2,
  • Nelson Dip1,
  • Carlo Camargo Passerotti1, 3,
  • Guilherme Ayres Rossini3,
  • Denis Reis Morais1,
  • Adriano Joao Nesrallah1, 2,
  • Camila Piantino1,
  • Miguel Srougi1, 2 and
  • Katia R Leite1, 2
BMC Urology201212:14

DOI: 10.1186/1471-2490-12-14

Received: 30 January 2012

Accepted: 4 May 2012

Published: 29 May 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
30 Jan 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Feb 2012 Reviewed Reviewer Report - Satoshi Anai
6 Mar 2012 Reviewed Reviewer Report - Evan Gomes
14 Mar 2012 Author responded Author comments - Sabrina Reis
Resubmission - Version 3
14 Mar 2012 Submitted Manuscript version 3
19 Mar 2012 Author responded Author comments - Sabrina Reis
29 Mar 2012 Reviewed Reviewer Report - Evan Gomes
Resubmission - Version 4
19 Mar 2012 Submitted Manuscript version 4
Publishing
4 May 2012 Editorially accepted
29 May 2012 Article published 10.1186/1471-2490-12-14

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Laboratory of Medical Investigation (LIM55), Urology Department, University of Sao Paulo Medical School
(2)
Uro-Oncology Group, Urology Department, University of Sao Paulo Medical School and Institute of Cancer Estate of Sao Paulo (ICESP)
(3)
Urology department, Nove de Julho University

Advertisement